Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers

PURPOSE: This study aimed to develop a nomogram for predicting pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (CRT) in patients with esophageal squamous cell carcinoma (ESCC) by integrating hematological biomarkers and clinicopathological characteristics. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yingjia, Chen, Jinbin, Zhao, Lei, Li, Qiaoqiao, Zhu, Jinhan, Yang, Hong, Guo, Suping, Xi, Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812014/
https://www.ncbi.nlm.nih.gov/pubmed/32898941
http://dx.doi.org/10.4143/crt.2020.594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812014/
https://www.ncbi.nlm.nih.gov/pubmed/32898941
http://dx.doi.org/10.4143/crt.2020.594

Ejemplares similares